News

The financing round finances the design verification and sample comparison study as well as a retrospective study with 3,600 frozen patient samples. The proceeds will also finance further development of new assays as well as the start of clinical trials, ISO 13485 certification and other operating expenses. Oslo, Norway, 25 April 2023 — SpinChip Diagnostics…

We are excited to welcome Glenn Gundersen to the SpinChip team as our new Head of Clinical and Medical Affairs. He will be responsible for leading our clinical programs for the validation of our Point of Care biomarker assays. Glenn brings more than 25 years of experience from the MedTech and pharmaceutical industry, ranging from small and…